Relationship between Drug Attitudes of Schizophrenic Patients on Discharge and Re-hospitalization
Abstract
Objective: Non-compliance is one of the major problems in treatment of patients with schizophrenia. It is also the most significant risk factor for relapse and re-hospitalization. Previous studies showed that 25-70% of all patients with schizophrenia have negative attitudes to drugs. Therefore, the present study aimed to identify the relationship between drug attitude and discharge and the rate of re-hospitalization in patients with schizophrenia.
Method: This cohort study was carried out on 200 hospitalized patients with schizophrenia. Drug Attitude Inventory (DAI) was completed for all the patients at the time of discharge. All patients were followed-up for one year forehospitalization. Logistic regression was used to examine the association between drug attitude and specific risk factors.
Results: The Mean age of patients was 37.3410.74 years. Positive and negative drug attitudes were 68%.5 and 27% respectively. The rate of rehospitalization was 41.5% during the one year follow-up. The rate of negative attitude was not significantly different between the two groups with and without re-hospitalization. However, the mean DAI score was significantly lower in the re-hospitalized patients. Multivariate analysis showed that lower DAI score and being female were significant and independent risk factors for re-hospitalization.
Conclusion: The more negative attitude the patients with schizophrenia had towards drugs, the more rate of re-hospitalization they had. Moreover, female patients are at higher risk for re-hospitalization.
Carpenter WT, Jr.,Buchanan RW. Schizophrenia. N Engl J Med 1994; 330: 681- 690.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). 4th ed. Washington, DC: American Psychiatric Press; 2000.
Coyle JT. The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry 1996; 3: 241-253.
Auquier P, Lancon C, Rouillon F, Lader M,Holmes C. Mortality in schizophrenia. Pharmacoepidemiol Drug Saf 2006; 15: 873- 879.
Andreasen NC, Arndt S, Alliger R, Miller D,Flaum M. Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch Gen Psychiatry 1995; 52: 341-351.
Docherty JP, Kozma C,Grogg A. Antipsychotic maintenance in schizophrenia: partial compliance and clinical outcome. Abstract 154. Presented at the annual meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, Dec 8–12, 2002.
Drake RE, Osher FC,Wallach MA. Alcohol use and abuse in schizophrenia. A prospective community study. J Nerv Ment Dis 1989; 177: 408-414.
Fenton WS, Blyler CR,Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997; 23: 637-651.
Garavan J, Browne S, Gervin M, Lane A, Larkin C,O'Callaghan E. Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight. Compr Psychiatry 1998; 39: 215-219.
Lacro JP, Dunn LB, Dolder CR, Leckband SG,Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002; 63: 892-909.
Marder SR. Facilitating compliance with antipsychotic medication. J Clin Psychiatry 1998; 59 Suppl 3: 21-25.
Razali MS,Yahya H. Compliance with treatment in schizophrenia: a drug intervention program in a developing country. Acta Psychiatr Scand 1995; 91: 331-335.
Young JL, Zonana HV,Shepler L. Medication noncompliance in schizophrenia: codification and update. Bull Am Acad Psychiatry Law 1986; 14: 105-122.
Kane JM. Review of treatments that can ameliorate nonadherence in patients with schizophrenia. J Clin Psychiatry 2006; 67 Suppl 5: 9-14.
Leucht S,Heres S. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. J Clin Psychiatry 2006; 67 Suppl 5: 3-8.
Haley CJ, Drake RJ, Bentall RP,Lewis SW. Health beliefs link to duration of untreated psychosis and attitudes to later treatment in early psychosis. Soc Psychiatry Psychiatr Epidemiol 2003; 38: 311-316.
McCann TV,Clark E. Attitudes of patients towards mental health nurse prescribing of antipsychotic agents. Int J Nurs Pract 2008; 14: 115-121.
Freudenreich O, Cather C, Evins AE, Henderson DC,Goff DC. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. J Clin Psychiatry 2004; 65: 1372- 1376.
Adewuya AO, Ola BA, Mosaku SK, Fatoye FO,Eegunranti AB. Attitude towards antipsychotics among out-patients with schizophrenia in Nigeria. Acta Psychiatr Scand 2006; 113: 207-211.
Anonymous. Mental Disorders; New mental disorders research from University of Turin described. Gastroenterology Week. Atlanta: 31Mar2008, pg. 430.
Degmecic D, Pozgain I,Filakovic P. Psychoeducation and compliance in the treatment of patients with schizophrenia. Coll Antropol 2007; 31: 1111-1115.
Tay SE. Compliance therapy: an intervention to improve inpatients' attitudes toward treatment. J Psychosoc Nurs Ment Health Serv 2007; 45: 29-37.
Hamann J, Cohen R, Leucht S, Busch R,Kissling W. Do patients with schizophrenia wish to be involved in decisions about their medical treatment? Am J Psychiatry 2005; 162: 2382-2384.
Hofer A, Rettenbacher MA, Edlinger M, Kemmler G, Widschwendter CG,Fleischhacker WW. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia. Acta Psychiatr Scand 2007; 116: 354-361.
Mohamed S, Rosenheck R, McEvoy J, Swartz M, Stroup S,Lieberman JA. Cross-sectional and Longitudinal Relationships Between Insight and Attitudes Toward Medication and Clinical Outcomes in Chronic Schizophrenia. Schizophr Bull 2008.
Stankovic Z, Britvic D, Vukovic O,Ille T. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables. Psychiatr Danub 2008; 20: 42-52.
Rocca P, Crivelli B, Marino F, Mongini T, Portaleone F,Bogetto F. Correlations of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophrenia. Compr Psychiatry 2008; 49: 170-176.
| Files | ||
| Issue | Vol 3 No 3 (2008) | |
| Section | Articles | |
| Keywords | ||
| Attitude Drug therapy Patient readmission Relapse Schizophrenia | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
